Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy

Trial Identifier: LB-001LT
Sponsor: Alexion Pharmaceuticals, Inc.
Collaborator:
Alexion Pharmaceuticals, Inc.
Start Date: July 2022
Primary Completion Date: January 2037
Study Completion Date: January 2037

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, Georgia Atlanta, Georgia, United States, 30322
United States, Pennsylvania Pittsburg, Pennsylvania, United States, 15224
United States, Tennessee Nashville, Tennessee, United States, 37232
United States, Washington Seattle, Washington, United States, 98105